Skip to content

News

Using Nanoparticles to Shrink Tumors in Mice

Using Nanoparticles to Shrink Tumors in Mice

08/23/2012 Reported online last week in Science Translational Medicine, researchers at MIT and Harvard used nanoparticles to demonstrate the nanoparticles that target a protein called ID4 can reduce ovarian cancer tumors in mice. Researchers hope that this approach could help speed the development of new drugs.  As new technology allows researchers to sequence cancer cell … Continued

Dose Dense Therapy Appears Beneficial

Dose Dense Therapy Appears Beneficial

A study of 637 Japanese women with ovarian, fallopian or primary peritoneal cancer showed that dose dense chemotherapy provided a benefit. The standard of care arm provided chemotherapy every three weeks, the dose dense arm provided one of the drugs every week and the other every three weeks. Women who were on the dose dense … Continued

Fertility Drugs Do Not Appear to Cause Ovarian Cancer

Fertility Drugs Do Not Appear to Cause Ovarian Cancer

A study of approximately 2700 women showed that women who used fertility drugs did not have a higher risk of ovarian cancer, except for women who used fertility drugs and never got pregnant. Read the full abstract here.

Taxane Therapy Does Not Affect Pregnancy

Taxane Therapy Does Not Affect Pregnancy

A small retrospective study of women receiving taxane therapy for breast or ovarian cancer while pregnancy showed no statistically significant outcomes in maternal or fetal health. Read the abstract here

Ovarian Cancer Screening May be Cost Effective, But Better ...

Ovarian Cancer Screening May be Cost Effective, But Better Biomarkers are Needed

08/09/2012 Research investigating the efficacy of screening women with a two-step screening strategy using CA125 and transvaginal sonogram (TVS) is ongoing, as are efforts to identify better biomarkers to identify the disease. In this context, researchers conducted a study evaluating the hypothetical impact on mortality, as well as the cost effectiveness of screening women at … Continued

Super Saturday 15 Raises a Record $3.6 Million for Ovarian ...

Super Saturday 15 Raises a Record $3.6 Million for Ovarian Cancer Research Fund

THE EVENT WAS HOSTED BY KELLY RIPA, PAULA PATTON, DONNA KARAN AND ARIEL FOXMAN AND PRESENTED BY QVC, COVERGIRL, INSTYLE New York, NY – August 6, 2012– Kelly Ripa, Paula Patton, Donna Karan and Ariel Foxman hosted Ovarian Cancer Research Fund’s (OCRF) 15th annual Super Saturday, presented by QVC, COVERGIRL and InStyle. The event raised … Continued

Partner Member Profile: Arkansas Ovarian Cancer Coalition

Partner Member Profile: Arkansas Ovarian Cancer Coalition

In early September, the skies over Arkansas will fill with butterflies and balloons to mark the start of National Ovarian Cancer Awareness Month. “It’s a way to kick off the month for survivors and supporters,” says Arkansas Ovarian Cancer Coalition (AROVCC) co-founder and board member Amy Lasseigne. “We hope people in Little Rock will see … Continued

When Less Is More – Editorial

When Less Is More – Editorial

The L.A. Times published an editorial July 29 summing up years of data showing that aggressively screening and treating people for cancer does not always benefit them. The editorial also points out that population based studies may not apply to people with known risk factors, like a family history of breast/ovarian cancer. The editorial also … Continued

Ovarian Cancer Patients with Robust Support Networks Live L...

Ovarian Cancer Patients with Robust Support Networks Live Longer

According to a study of 186 women with ovarian cancer, women with high levels of emotional support lived longer than women without them. The study also suggests that a high degree of “instrumental support” – that is, tangible assistance – did not have any effect on survival. Read the abstract here

Research Shows Ovarian Cancer Patients with Social Support ...

Research Shows Ovarian Cancer Patients with Social Support Live Longer

07/19/2012Research published July 16th in the Journal of Clinical Oncology shows that greater social attachment was associated with a lower likelihood of death for ovarian cancer patients. A group of researchers, including senior author and OCRF grantee Anil Sood, MD examined how social support related to long term survival.  Two types of social support were … Continued

More Research Confirms No Link Between Fertility Drugs and ...

More Research Confirms No Link Between Fertility Drugs and Ovarian Cancer Risk

07/18/2012 A study published in Cancer Epidemiology, Biomarkers, and Prevention this month re-confirms that there is no link between use of fertility drugs and an elevated risk of ovarian cancer. While in the past studies on this subject have produced conflicting results, this study adds to the increasing body of work showing that use of … Continued

Kelly Ripa, Paula Patton, Donna Karan, Ariel Foxman to Host...

Kelly Ripa, Paula Patton, Donna Karan, Ariel Foxman to Host Ovarian Cancer Research Fund’s World Famous Garage Sale

SUPER SATURDAY 15 PRESENTED BY QVC, COVERGIRL, INSTYLE SATURDAY, JULY 28TH IN WATERMILL, NY New York, NY – July 13, 2012– Kelly Ripa, Paula Patton, Donna Karan and Ariel Foxman will host Ovarian Cancer Research Fund’s (OCRF) 15th annual Super Saturday, presented by, QVC, COVERGIRL and InStyle. Super Saturday 15 will take place on Saturday, … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.